Consolidated Statement Of Comprehensive Income

Delta-Fly Pharma, Inc. - Filing #7246013

Concept 2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
Consolidated statement of comprehensive income
Statement of comprehensive income
Profit (loss)
-1,721,164,000 JPY
-1,721,164,000 JPY
-1,721,164,000 JPY
-1,721,164,000 JPY
-1,429,393,000 JPY
-1,429,393,000 JPY
-1,429,393,000 JPY
-1,429,393,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.